SE0101232D0 - Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based elisa for determination of immune responses against oxidized low density liprotein - Google Patents

Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based elisa for determination of immune responses against oxidized low density liprotein

Info

Publication number
SE0101232D0
SE0101232D0 SE0101232A SE0101232A SE0101232D0 SE 0101232 D0 SE0101232 D0 SE 0101232D0 SE 0101232 A SE0101232 A SE 0101232A SE 0101232 A SE0101232 A SE 0101232A SE 0101232 D0 SE0101232 D0 SE 0101232D0
Authority
SE
Sweden
Prior art keywords
peptide
atherosclerosis
determination
development
treatment
Prior art date
Application number
SE0101232A
Other languages
English (en)
Inventor
Jan Nilsson
Original Assignee
Forskarpatent I Syd Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Forskarpatent I Syd Ab filed Critical Forskarpatent I Syd Ab
Priority to SE0101232A priority Critical patent/SE0101232D0/sv
Publication of SE0101232D0 publication Critical patent/SE0101232D0/sv
Priority to SE0103754A priority patent/SE0103754L/sv
Priority to US10/115,072 priority patent/US20030105003A1/en
Priority to EP02714667A priority patent/EP1383526B1/en
Priority to EP10180109A priority patent/EP2289913A1/en
Priority to BRPI0216049A priority patent/BRPI0216049B8/pt
Priority to CA2443223A priority patent/CA2443223C/en
Priority to EP10181227A priority patent/EP2289932A1/en
Priority to EEP200300487A priority patent/EE200300487A/xx
Priority to DE60230029T priority patent/DE60230029D1/de
Priority to EP10180188A priority patent/EP2289916A1/en
Priority to EP10181263A priority patent/EP2295463A1/en
Priority to EP10180111A priority patent/EP2289914A1/en
Priority to EP10180026A priority patent/EP2295457A1/en
Priority to EP08167532A priority patent/EP2147680A3/en
Priority to EP10181196A priority patent/EP2289928A1/en
Priority to EEP200700052A priority patent/EE200700052A/xx
Priority to ES10181267.5T priority patent/ES2546293T3/es
Priority to EP10181173A priority patent/EP2289926A1/en
Priority to BR0208685-9A priority patent/BR0208685A/pt
Priority to AU2002246484A priority patent/AU2002246484B8/en
Priority to EP10180115A priority patent/EP2305707A1/en
Priority to EP10181273A priority patent/EP2289935A1/en
Priority to EP10180176A priority patent/EP2305708A1/en
Priority to BRPI0216033A priority patent/BRPI0216033B8/pt
Priority to PL400308A priority patent/PL400308A1/pl
Priority to EP10180828A priority patent/EP2289921A1/en
Priority to EP10180823A priority patent/EP2289919A1/en
Priority to DK02714667T priority patent/DK1383526T3/da
Priority to EP10180172A priority patent/EP2289915A1/en
Priority to AT02714667T priority patent/ATE415423T1/de
Priority to EP10180099A priority patent/EP2295458A1/en
Priority to CN201210322795.9A priority patent/CN103122031B/zh
Priority to EP10180184A priority patent/EP2295462A1/en
Priority to EP08167533A priority patent/EP2147930A3/en
Priority to EP08151489A priority patent/EP2006301B1/en
Priority to EP10181245A priority patent/EP2289933A1/en
Priority to EP10180199A priority patent/EP2289918A1/en
Priority to EP08167531A priority patent/EP2147929A3/en
Priority to EP10181267.5A priority patent/EP2295464B1/en
Priority to EP10181203A priority patent/EP2289929A1/en
Priority to PL02367301A priority patent/PL367301A1/xx
Priority to EP10180193A priority patent/EP2289917A1/en
Priority to EP10180838A priority patent/EP2289923A1/en
Priority to EP10180162.9A priority patent/EP2295460B1/en
Priority to EP10180835A priority patent/EP2289922A1/en
Priority to EP08158141A priority patent/EP2147928A3/en
Priority to EP10181167A priority patent/EP2289925A1/en
Priority to EP10181213A priority patent/EP2289930A1/en
Priority to DK10181267.5T priority patent/DK2295464T3/en
Priority to CA2606839A priority patent/CA2606839C/en
Priority to EP10180156A priority patent/EP2295459A1/en
Priority to AT08151489T priority patent/ATE510851T1/de
Priority to PL385189A priority patent/PL215401B1/pl
Priority to RU2003132443/15A priority patent/RU2296582C2/ru
Priority to PT02714667T priority patent/PT1383526E/pt
Priority to CNA2009100095655A priority patent/CN101486766A/zh
Priority to EP10180106A priority patent/EP2289912A1/en
Priority to DK08151489.5T priority patent/DK2006301T3/da
Priority to PCT/SE2002/000679 priority patent/WO2002080954A1/en
Priority to CN2007101953989A priority patent/CN101284874B/zh
Priority to EP10180845A priority patent/EP2289924A1/en
Priority to EP10180826A priority patent/EP2289920A1/en
Priority to EP10180091A priority patent/EP2305706A1/en
Priority to CN028089405A priority patent/CN1505525B/zh
Priority to EP10181217A priority patent/EP2289931A1/en
Priority to EP10181253.5A priority patent/EP2289934B1/en
Priority to EP07119130A priority patent/EP1918300A3/en
Priority to CA2827167A priority patent/CA2827167A1/en
Priority to EP10180168A priority patent/EP2295461A1/en
Priority to EP10181188A priority patent/EP2289927A1/en
Priority to ES02714667T priority patent/ES2317999T3/es
Priority to IL15828502A priority patent/IL158285A0/xx
Priority to PL391615A priority patent/PL217858B1/pl
Priority to ES08151489T priority patent/ES2367146T3/es
Priority to JP2002578993A priority patent/JP2004529143A/ja
Priority to IL158285A priority patent/IL158285A/en
Priority to US11/485,549 priority patent/US7537758B2/en
Priority to US11/924,010 priority patent/US7527795B2/en
Priority to US11/930,859 priority patent/US7544360B2/en
Priority to US11/930,910 priority patent/US7556811B2/en
Priority to US11/930,625 priority patent/US7528225B2/en
Priority to US11/930,969 priority patent/US20090117137A1/en
Priority to IL188286A priority patent/IL188286A0/en
Priority to JP2008015545A priority patent/JP2008169215A/ja
Priority to IL195356A priority patent/IL195356A0/en
Priority to CY20091100202T priority patent/CY1108817T1/el
Priority to US12/394,744 priority patent/US20090226475A1/en
Priority to US12/394,787 priority patent/US7785589B2/en
Priority to US12/394,919 priority patent/US8034336B2/en
Priority to US12/394,886 priority patent/US8029786B2/en
Priority to US12/394,857 priority patent/US7704499B2/en
Priority to US12/394,827 priority patent/US8025876B2/en
Priority to JP2009133383A priority patent/JP5270456B2/ja
Priority to US12/644,810 priority patent/US20100183706A1/en
Priority to JP2010239477A priority patent/JP5300819B2/ja
Priority to JP2010239478A priority patent/JP5300820B2/ja
Priority to US13/177,897 priority patent/USRE43581E1/en
Priority to US13/736,645 priority patent/US8470768B2/en
Priority to US13/736,644 priority patent/US8642726B2/en
Priority to US13/736,633 priority patent/US8647628B2/en
Priority to US13/736,636 priority patent/US8642043B2/en
Priority to JP2013034312A priority patent/JP5613890B2/ja

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0012—Lipids; Lipoproteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/775—Apolipopeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Mycology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SE0101232A 2001-04-05 2001-04-05 Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based elisa for determination of immune responses against oxidized low density liprotein SE0101232D0 (sv)

Priority Applications (103)

Application Number Priority Date Filing Date Title
SE0101232A SE0101232D0 (sv) 2001-04-05 2001-04-05 Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based elisa for determination of immune responses against oxidized low density liprotein
SE0103754A SE0103754L (sv) 2001-04-05 2001-11-09 Peptider från apolipoprotein B, användning därav immunisering, diagnosmetod eller terapeutisk behandling av ischemiska kardiovaskulära sjukdomar, samt farmaceutisk komposition och vaccin innehållande sådan peptid
US10/115,072 US20030105003A1 (en) 2001-04-05 2002-04-04 Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein
EP02714667A EP1383526B1 (en) 2001-04-05 2002-04-05 Immunization therapy for treatment of atherosclerosis
EP10180109A EP2289913A1 (en) 2001-04-05 2002-04-05 Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein
BRPI0216049A BRPI0216049B8 (pt) 2001-04-05 2002-04-05 "terapia de imunização à base de peptídeo para tratamento de arteriosclerose"
CA2443223A CA2443223C (en) 2001-04-05 2002-04-05 Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein
EP10181227A EP2289932A1 (en) 2001-04-05 2002-04-05 Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein
EEP200300487A EE200300487A (et) 2001-04-05 2002-04-05 Peptiid-põhine immunoteraapia ateroskleroosi raviks ja peptiid-põhise määramise arendamine immuunvastuste määramiseks oksüdeeritud madala tihedusega lipoproteiini vastu
DE60230029T DE60230029D1 (de) 2001-04-05 2002-04-05 Immunisierungstherapie zur behandlung von atherosklerose
EP10180188A EP2289916A1 (en) 2001-04-05 2002-04-05 Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein
EP10181263A EP2295463A1 (en) 2001-04-05 2002-04-05 Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein
EP10180111A EP2289914A1 (en) 2001-04-05 2002-04-05 Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein
EP10180026A EP2295457A1 (en) 2001-04-05 2002-04-05 Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein
EP08167532A EP2147680A3 (en) 2001-04-05 2002-04-05 Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein
EP10181196A EP2289928A1 (en) 2001-04-05 2002-04-05 Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein
EEP200700052A EE200700052A (et) 2001-04-05 2002-04-05 Antikeha he v?i mitme apo-lipoproteiin B fragmendi vastu
ES10181267.5T ES2546293T3 (es) 2001-04-05 2002-04-05 Terapia de inmunización basada en péptidos para el tratamiento de aterosclerosis que fija ApoB como objetivo
EP10181173A EP2289926A1 (en) 2001-04-05 2002-04-05 Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein
BR0208685-9A BR0208685A (pt) 2001-04-05 2002-04-05 Terapia de imunização à base de peptìdio para tratamento de arteriosclerose e desenvolvimento de ensaio à base de peptìdio para determinação de respostas imunes contra lipoproteìna oxidada de baixa densidade
AU2002246484A AU2002246484B8 (en) 2001-04-05 2002-04-05 Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein
EP10180115A EP2305707A1 (en) 2001-04-05 2002-04-05 Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein
EP10181273A EP2289935A1 (en) 2001-04-05 2002-04-05 Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein
EP10180176A EP2305708A1 (en) 2001-04-05 2002-04-05 Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein
BRPI0216033A BRPI0216033B8 (pt) 2001-04-05 2002-04-05 "terapia de imunização à base de peptídio para tratamento de arteriosclerose"
PL400308A PL400308A1 (pl) 2001-04-05 2002-04-05 Terapia immunizacyjna w oparciu o peptydy do leczenia miazdzycy oraz w oparciu o peptydy do okreslania odpowiedzi odpornosci przeciwko utlenionym lipoproteinom o niskiej gestosci
EP10180828A EP2289921A1 (en) 2001-04-05 2002-04-05 Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein
EP10180823A EP2289919A1 (en) 2001-04-05 2002-04-05 Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein
DK02714667T DK1383526T3 (da) 2001-04-05 2002-04-05 Immuniseringsterapi til behandling af aterosklerose
EP10180172A EP2289915A1 (en) 2001-04-05 2002-04-05 Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein
AT02714667T ATE415423T1 (de) 2001-04-05 2002-04-05 Immunisierungstherapie zur behandlung von atherosklerose
EP10180099A EP2295458A1 (en) 2001-04-05 2002-04-05 Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein
CN201210322795.9A CN103122031B (zh) 2001-04-05 2002-04-05 以肽为基础的治疗动脉粥样硬化的免疫疗法
EP10180184A EP2295462A1 (en) 2001-04-05 2002-04-05 Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein
EP08167533A EP2147930A3 (en) 2001-04-05 2002-04-05 Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein
EP08151489A EP2006301B1 (en) 2001-04-05 2002-04-05 Peptide-based immunization therapy for treatment of atherosclerosis
EP10181245A EP2289933A1 (en) 2001-04-05 2002-04-05 Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein
EP10180199A EP2289918A1 (en) 2001-04-05 2002-04-05 Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein
EP08167531A EP2147929A3 (en) 2001-04-05 2002-04-05 Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein
EP10181267.5A EP2295464B1 (en) 2001-04-05 2002-04-05 Peptide-based immunization therapy for treatment of atherosclerosis targeting ApoB100
EP10181203A EP2289929A1 (en) 2001-04-05 2002-04-05 Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein
PL02367301A PL367301A1 (en) 2001-04-05 2002-04-05 Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein
EP10180193A EP2289917A1 (en) 2001-04-05 2002-04-05 Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein
EP10180838A EP2289923A1 (en) 2001-04-05 2002-04-05 Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein
EP10180162.9A EP2295460B1 (en) 2001-04-05 2002-04-05 Peptide- or antibody-based immunization therapy for treatment of atherosclerosis targeting ApoB100
EP10180835A EP2289922A1 (en) 2001-04-05 2002-04-05 Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein
EP08158141A EP2147928A3 (en) 2001-04-05 2002-04-05 Peptide-based immunization therapy for treatment of atherosclerososis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein
EP10181167A EP2289925A1 (en) 2001-04-05 2002-04-05 Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein
EP10181213A EP2289930A1 (en) 2001-04-05 2002-04-05 Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein
DK10181267.5T DK2295464T3 (en) 2001-04-05 2002-04-05 Peptide-based immunization therapy for the treatment of atherosclerosis targeting ApoB100
CA2606839A CA2606839C (en) 2001-04-05 2002-04-05 Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein
EP10180156A EP2295459A1 (en) 2001-04-05 2002-04-05 Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein
AT08151489T ATE510851T1 (de) 2001-04-05 2002-04-05 Auf peptiden basierende immunisierungstherapie zur behandlung von atherosklerose
PL385189A PL215401B1 (pl) 2001-04-05 2002-04-05 Fragment apolipoproteiny B lub jego miejsce aktywne, zawierajaca go kompozycja farmaceutyczna i szczepionka, zastosowanie tego fragmentu , szczepionka zawierajaca przeciwcialo przeciwko temu fragmentowi, sposób diagnozowania in vitro oraz zastosowanie tego przeciwciala
RU2003132443/15A RU2296582C2 (ru) 2001-04-05 2002-04-05 Фрагменты пептидов, фармацевтические композиции и вакцины на их основе и их применение для профилактики и терапии атеросклероза
PT02714667T PT1383526E (pt) 2001-04-05 2002-04-05 Terapia de imunização para o tratamento de aterosclerose
CNA2009100095655A CN101486766A (zh) 2001-04-05 2002-04-05 以肽为基础的治疗动脉粥样硬化的免疫疗法，和以肽为基础的用于确定针对氧化低密度脂蛋白的免疫反应的检测方法
EP10180106A EP2289912A1 (en) 2001-04-05 2002-04-05 Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein
DK08151489.5T DK2006301T3 (da) 2001-04-05 2002-04-05 Peptid-baseret immuniseringsterapi til behandling af atherosklerose
PCT/SE2002/000679 WO2002080954A1 (en) 2001-04-05 2002-04-05 Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein
CN2007101953989A CN101284874B (zh) 2001-04-05 2002-04-05 以肽为基础的治疗动脉粥样硬化的免疫疗法
EP10180845A EP2289924A1 (en) 2001-04-05 2002-04-05 Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein
EP10180826A EP2289920A1 (en) 2001-04-05 2002-04-05 Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein
EP10180091A EP2305706A1 (en) 2001-04-05 2002-04-05 Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein
CN028089405A CN1505525B (zh) 2001-04-05 2002-04-05 以肽为基础的治疗动脉粥样硬化的免疫疗法,和以肽为基础的用于确定针对氧化低密度脂蛋白的免疫反应的检测方法
EP10181217A EP2289931A1 (en) 2001-04-05 2002-04-05 Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein
EP10181253.5A EP2289934B1 (en) 2001-04-05 2002-04-05 Peptide-based immunization therapy for treatment of atherosclerosis
EP07119130A EP1918300A3 (en) 2001-04-05 2002-04-05 Peptide-based immunization therapy for treatment of atherosclerosis
CA2827167A CA2827167A1 (en) 2001-04-05 2002-04-05 Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein
EP10180168A EP2295461A1 (en) 2001-04-05 2002-04-05 Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein
EP10181188A EP2289927A1 (en) 2001-04-05 2002-04-05 Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein
ES02714667T ES2317999T3 (es) 2001-04-05 2002-04-05 Terapia de inmunizacion para el tratamiento de la ateroesclerosis.
IL15828502A IL158285A0 (en) 2001-04-05 2002-04-05 Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-base assay for determination of immune responses against oxidized low density lipoprotein
PL391615A PL217858B1 (pl) 2001-04-05 2002-04-05 Fragment apolipoproteiny B lub jego miejsce aktywne, zawierająca go kompozycja farmaceutyczna i szczepionka, zastosowanie tego fragmentu, szczepionka zawierająca przeciwciało przeciwko temu fragmentowi, sposób diagnozowania in vitro oraz zastosowanie tego przeciwciała
ES08151489T ES2367146T3 (es) 2001-04-05 2002-04-05 Terapia de inmunización basadas en péptidos para el tratamiento de aterosclerosis.
JP2002578993A JP2004529143A (ja) 2001-04-05 2002-04-05 アテローム性動脈硬化症の治療のためのペプチドに基づいた免疫治療、及び酸化した低密度リポ蛋白質に対する免疫応答の測定のためのペプチドベースのアッセーの開発
IL158285A IL158285A (en) 2001-04-05 2003-10-07 Peptides for preparing medicament for immuno- therapy of atherosclerosis and development of peptide-base assay for determination of immune responses against oxidized low density lipoprotein
US11/485,549 US7537758B2 (en) 2001-04-05 2006-07-12 Antibodies against a peptide epitope of apolipoprotein B
US11/924,010 US7527795B2 (en) 2001-04-05 2007-10-25 Peptide epitopes of apolipoprotein B
US11/930,859 US7544360B2 (en) 2001-04-05 2007-10-31 Peptide epitopes of apolipoprotein B
US11/930,910 US7556811B2 (en) 2001-04-05 2007-10-31 Peptide epitopes of apolipoprotein B
US11/930,625 US7528225B2 (en) 2001-04-05 2007-10-31 Peptide epitopes of apolipoprotein B
US11/930,969 US20090117137A1 (en) 2001-04-05 2007-10-31 Peptide epitopes of apolipoprotein b
IL188286A IL188286A0 (en) 2001-04-05 2007-12-20 Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein
JP2008015545A JP2008169215A (ja) 2001-04-05 2008-01-25 アテローム性動脈硬化症の治療のためのペプチドに基づいた免疫治療、及び酸化した低密度リポ蛋白質に対する免疫応答の測定のためのペプチドベースのアッセーの開発
IL195356A IL195356A0 (en) 2001-04-05 2008-11-18 Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein
CY20091100202T CY1108817T1 (el) 2001-04-05 2009-02-24 Ανοσολογικη θεραπεια για την αντιμετωπιση της αθηροσκληρωσης
US12/394,744 US20090226475A1 (en) 2001-04-05 2009-02-27 Peptide-based immunization therapy for treatment of atherosclerosis
US12/394,787 US7785589B2 (en) 2001-04-05 2009-02-27 Antibodies against a peptide epitope of apolipoprotein B
US12/394,919 US8034336B2 (en) 2001-04-05 2009-02-27 Antibodies against a peptide epitope of apoliprotein B
US12/394,886 US8029786B2 (en) 2001-04-05 2009-02-27 Antibodies against a peptide epitope of apolipoprotein B
US12/394,857 US7704499B2 (en) 2001-04-05 2009-02-27 Antibodies against a peptide epitope of apoliporotein B
US12/394,827 US8025876B2 (en) 2001-04-05 2009-02-27 Antibodies against a peptide epitope of apolipoprotein B
JP2009133383A JP5270456B2 (ja) 2001-04-05 2009-06-02 アテローム性動脈硬化症の治療のためのペプチドに基づいた免疫治療、及び酸化した低密度リポ蛋白質に対する免疫応答の測定のためのペプチドベースのアッセーの開発
US12/644,810 US20100183706A1 (en) 2001-04-05 2009-12-22 Peptide epitopes of apolipoprotein b
JP2010239477A JP5300819B2 (ja) 2001-04-05 2010-10-26 アテローム性動脈硬化症の治療のためのペプチドに基づいた免疫治療、及び酸化した低密度リポ蛋白質に対する免疫応答の測定のためのペプチドベースのアッセーの開発
JP2010239478A JP5300820B2 (ja) 2001-04-05 2010-10-26 アテローム性動脈硬化症の治療のためのペプチドに基づいた免疫治療、及び酸化した低密度リポ蛋白質に対する免疫応答の測定のためのペプチドベースのアッセーの開発
US13/177,897 USRE43581E1 (en) 2001-04-05 2011-07-07 Peptide epitopes of apolipoprotein B
US13/736,645 US8470768B2 (en) 2001-04-05 2013-01-08 Peptide epitopes of apolipoprotein B
US13/736,644 US8642726B2 (en) 2001-04-05 2013-01-08 Peptide epitopes of apolipoprotein B
US13/736,633 US8647628B2 (en) 2001-04-05 2013-01-08 Peptide epitopes of apolipoprotein B
US13/736,636 US8642043B2 (en) 2001-04-05 2013-01-08 Peptide epitopes of apolipoprotein B
JP2013034312A JP5613890B2 (ja) 2001-04-05 2013-02-25 アテローム性動脈硬化症の治療のためのペプチドに基づいた免疫治療、及び酸化した低密度リポ蛋白質に対する免疫応答の測定のためのペプチドベースのアッセーの開発

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0101232A SE0101232D0 (sv) 2001-04-05 2001-04-05 Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based elisa for determination of immune responses against oxidized low density liprotein

Publications (1)

Publication Number Publication Date
SE0101232D0 true SE0101232D0 (sv) 2001-04-05

Family

ID=20283699

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0101232A SE0101232D0 (sv) 2001-04-05 2001-04-05 Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based elisa for determination of immune responses against oxidized low density liprotein

Country Status (2)

Country Link
ES (1) ES2367146T3 (sv)
SE (1) SE0101232D0 (sv)

Also Published As

Publication number Publication date
ES2367146T3 (es) 2011-10-28

Similar Documents

Publication Publication Date Title
NO20033387D0 (no) Modifiserte antistoffer og fremgangsmåter for anvendelse
CY2019022I2 (el) Ανθρωπινα cdr-μοσχευμενα αντισωματα και θραυσματα αντισωματων τους
NO20023487D0 (no) Proteiner som omfatter konserverte regioner av Neisseria menigittidis overflate antigen NhhA
NO20041582L (no) Antistoffinhibitorer av GDF-8 og anvendelse derav
NO20011964D0 (no) Brönnbehandlingsfluider og fremgangsmåter med anvendelse derav
NO20035326D0 (no) Anordning og fremgangsmåte for behandling med magnetfelt
NO20023788L (no) Antistoff som binder humant interleukin-18 samt fremgangsmater ved fremstilling og anvendelse derav
NO20033418L (no) Immunregulatoriske antistoffer og anvendelse derav
ID25792A (id) Antibodi-antibodi terhadap cd40 manusia
DE60330335D1 (de) Endoskopinformationsprozessor und verarbeitungsmethode
EE05507B1 (et) Rosuvastatiini ZD4522) kasutamine heterosgootseperekondliku hperkolesteroleemia raviks
DK1411064T3 (da) Gangliosid-associerede rekombinante antistoffer og anvendelsen deraf i diagnosen og behandlingen af tumorer
DE60239627D1 (de) Signalverarbeitungsverfahren und prozessor
NO20033854D0 (no) N-but-3-enyl-norbuprenorfin og fremgangsmåter for anvendelse
NO20034080L (no) Fremgangsmåte og sett for deteksjon av neurodegenerative sykdommer
IS6966A (is) Cýanó-tengd díhýdrópýrimídín efnasambönd og notkun þeirra við meðhöndlun sjúkdóma
NO20041345L (no) Kopolymerer for undertrykkelse av autoimmune sykdommer og fremgangsmate for anvendelse
MA26220A1 (fr) Catheter et methode d'utilisation
IS6967A (is) Ný cýanó-tengd díhýdrópýrimídín efnasambönd og notkun þeirra við meðhöndlun sjúkdóma
NO20033506D0 (no) Parasittdrepende preparater og fremgangsmåter for anvendelse
DK1381382T3 (da) Fremgangsmåder og præparater til behandling af öjensygdomme
DE60232497D1 (de) Poliervorrichtung und -verfahren
ATA17962001A (de) Wölb-verwind-komfort- und therapie-stütze
NO20033263D0 (no) System og fremgangsmåte for å redigere data-genererte dokumenter uavhengigav programvare benyttet
NO20010464L (no) FremgangsmÕter og preparater for behandling av gastro- øsofagealt-reflukssyndrom